Product Description
Product Name: Didanosine Delayed-Release Capsules
Active Ingredient: Didanosine (ddI)
Form: Delayed-Release Oral Capsule
Category: Antiretroviral (Nucleoside Reverse Transcriptase Inhibitor – NRTI)
Indication: Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Didanosine, also known as ddI, is a nucleoside reverse transcriptase inhibitor (NRTI) used in combination with other antiretroviral agents for the treatment of HIV-1 infection. By interfering with the activity of the reverse transcriptase enzyme, didanosine prevents the replication of the virus, helping to lower HIV viral load and improve immune function.
